Paysign, Inc. PAYS
9.91 USD +0.37 (+3.88%)
As ofNov 17, 2026, 10:05 AM EST
9.48 Day range 9.95
3.08 52-week range 16.15
- YTD
- +92.43%
- 1 year
- +95.85%
News
fool.com Paysign: 3 Key Takeaways for Long-Term Investors Pharma patient affordability revenue grew 110% year-over-year to $16.6 million. Losing 113 plasma centers reduces fourth-quarter revenue by $1.5 million.
zacks.com Is Paysign (PAYS) a Solid Growth Stock? 3 Reasons to Think "Yes" Paysign (PAYS) possesses solid growth attributes, which could help it handily outperform the market.
zacks.com All You Need to Know About Paysign (PAYS) Rating Upgrade to Buy Paysign (PAYS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
zacks.com Down 39.2% in 4 Weeks, Here's Why Paysign (PAYS) Looks Ripe for a Turnaround Paysign (PAYS) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising…
seekingalpha.com Paysign's Post-Q3 Selloff Opens An Opportunity Paysign is rated a Buy at $10 despite losing a major plasma customer, as the selloff is seen as exaggerated. The Pharma segment now drives over half of revenue, growing 110% with higher margins and a…benzinga.com Ladenburg Thalmann Maintains Buy on PaySign, Raises Price Target to $15.25 Ladenburg Thalmann analyst Jon Hickman maintains PaySign (NASDAQ:PAYS) with a Buy and raises the price target from $14 to $15.25.
benzinga.com DA Davidson Maintains Buy on PaySign, Lowers Price Target to $14 DA Davidson analyst Peter Heckmann maintains PaySign (NASDAQ:PAYS) with a Buy and lowers the price target from $15 to $14.
benzinga.com PaySign Q3 2026 Earnings Call Transcript PaySign (NASDAQ:PAYS) reported third-quarter financial results on Monday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you by…benzinga.com PaySign Raises FY2026 GAAP EPS Guidance from $0.35-$0.37 to $0.37-$0.38 vs $0.34 Est; Affirms FY2026 Sales Guidance of $114.000M-$117.000M vs $114.659M Est PaySign (NASDAQ:PAYS) raises FY2026 GAAP EPS guidance from $0.35-$0.37 to $0.37-$0.38 vs $0.34 analyst estimate. Affirms FY2026 sales outlook from $114.000 million-$117.000 million to $114.000…
benzinga.com PaySign Q3 EPS $0.11 Beats $0.09 Estimate, Sales $30.800M Beat $29.019M Estimate PaySign (NASDAQ:PAYS) reported quarterly earnings of $0.11 per share which beat the analyst consensus estimate of $0.09 by 22.22 percent. This is a 175 percent increase over earnings of $0.04 per…
